Pharmexa to acquire Affitech - MarketLine Financial Deals

Pharmexa to acquire Affitech

Pharmexa to acquire Affitech - MarketLine Financial Deals
Pharmexa to acquire Affitech
Published Mar 03, 2009
2 pages — Published Mar 03, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Pharmexa A/S, a biotechnology company, has agreed to acquire 100% of the outstanding and issued shares in Affitech AS, a biotechnology. Both the companies are based in Denmark.

  
Source:
Document ID
MA02133_090305
Country
Country
Ticker
PHARMX=DK
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Pharmexa to acquire Affitech" Mar 03, 2009. Alacra Store. Dec 02, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Pharmexa-to-acquire-Affitech-2052-2042>
  
APA:
MarketLine Financial Deals. (2009). Pharmexa to acquire Affitech Mar 03, 2009. New York, NY: Alacra Store. Retrieved Dec 02, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Pharmexa-to-acquire-Affitech-2052-2042>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.